You are here

Coronavirus (COVID-19): Information on medicines and medical devices

The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page.

Please read the information below before contacting the TGA to see if your question is already answered.

17 May 2022

COVID-19 vaccines undergoing evaluation for provisional registration by the TGA

17 May 2022
The TGA is undertaking a post-market review of face masks included in the ARTG. This page lists all face masks that have been cancelled from the ARTG during the review.
16 May 2022

COVID-19 vaccine batch release information is now available.

16 May 2022
The TGA is undertaking a post-market review of all face masks included in the Australian Register of Therapeutic Goods to ensure the quality and effectiveness of face masks.
2 May 2022

The TGA has provisionally approved a booster dose of the Pfizer Australia Pty Ltd COVID-19 vaccine, COMIRNATY, for individuals 18 years and older.

28 April 2022
The TGA has granted a number of provisional determinations in relation to COVID-19 vaccines.
8 February 2022

Find information on complying with the rules around advertising and importing COVID-19 vaccines

17 December 2021
Information about a TGA post-market review of face masks, including guidance for suppliers and users of face masks.
9 December 2021
An overview of the regulation of Personal Protective Equipment (PPE) in Australia, including face masks, gowns and gloves.
5 November 2021

Action in relation to non-compliant face masks will be published on the TGA web site

Pages

Further information

Contact TGA Info

Tel: 1800 020 653
Email: info@tga.gov.au

Note: we are currently experiencing a high volume of calls and emails. Please bear with us as we try to respond to queries as quickly as possible.

Department of Health

Coronavirus (COVID-19) health alert — for information and advice not specific to therapeutic goods.

Follow us